Search clinical trials for: Malignant melanoma
Total 8263 results
-
National Cancer Institute (NCI)Fox Chase Cancer CenterCompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin MelanomaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustCompletedA Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread (NICAM)Mucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited Kingdom
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Genentech, Inc.Terminated
-
Universitair Ziekenhuis BrusselRIZIVCompletedMalignant Melanoma Stage III | Malignant Melanoma Stage IVBelgium
-
Stanford UniversityNational Cancer Institute (NCI)CompletedRecurrent MelanomaUnited States
-
Cancer Trials IrelandCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Melanoma (Skin)Ireland
-
Merck Sharp & Dohme LLCQuintiles, Inc.CompletedMelanoma | Carcinoma, Non-Small-Cell Lung | Breast Neoplasm | Metastases of Central Nervous System
-
University Hospital TuebingenDermatologic Cooperative Oncology GroupCompleted
-
University Hospital TuebingenUniversity Hospital DresdenUnknownMalignant Melanoma | MetastasesGermany
-
University Hospital TuebingenUnknownMalignant Melanoma Stage IVGermany
-
Hoffmann-La RocheCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
University of UtahTerminatedMelanoma | CancerUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)TerminatedIntraocular Melanoma | Malignant Conjunctival NeoplasmUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsKorea, Republic of, Brazil, United States, Canada, Cyprus
-
Novo Nordisk A/STerminatedCancer | Malignant MelanomaGermany
-
Haukeland University HospitalNorwegian Cancer Society; The Norwegian Melanoma GroupTerminatedMetastatic Malignant Melanoma | Unresectable Malignant MelanomaNorway
-
H. Lee Moffitt Cancer Center and Research InstituteNational Gene Vector LaboratoryCompletedMalignant MelanomaUnited States
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Hoffmann-La RocheCompletedRenal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant MelanomaCanada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
-
Baylor Research InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMalignant Melanoma Stage III | Malignant Melanoma Stage IVUnited States
-
Craig L Slingluff, JrNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Malignant Conjunctival Neoplasm | Melanoma (Skin)United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedMetastatic Cancer | Melanoma (Skin)United States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsUnited States, South Africa, Croatia, Brazil, Egypt
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pfizer; Beth Israel Deaconess Medical CenterCompletedMucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited States
-
Case Comprehensive Cancer CenterWithdrawnSmall Cell Lung Cancer | Non Small Cell Lung Cancer | Mesothelioma | Urothelial Cancer | Malignant Melanoma | Advanced Triple Negative Breast Cancer
-
Novartis PharmaceuticalsCompletedLife Threatening Diseases
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheWithdrawn
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
Genentech, Inc.CompletedMalignant MelanomaUnited States, Australia
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma | Malignant Mesothelioma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Gestational Trophoblastic Tumor | Cervical Adenocarcinoma and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
Bristol-Myers SquibbCompletedUnresectable Stage III or IV Malignant MelanomaUnited States, Peru, Norway, Italy, Sweden, Denmark, Israel
-
Bristol-Myers SquibbMedarexCompletedMalignant MelanomaUnited States, Peru, Canada, Israel, Italy, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
Oslo University HospitalCompleted
-
Massachusetts Eye and Ear InfirmaryM.D. Anderson Cancer Center; Wills EyeTerminatedNevus | Racial Melanosis | Primary Acquired Melanosis | Conjunctival Malignant MelanomaUnited States
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedMalignant MelanomaSpain, United States, Canada, Germany, Netherlands, France, Italy, United Kingdom, Israel, Australia
-
National Cancer Institute (NCI)National Institutes of Health Clinical Center (CC)TerminatedMetastatic Cancer | Metastatic MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Nodular Malignant Melanoma | Solar Radiation-related Skin Melanoma | Superficial Spreading Malignant MelanomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
Massachusetts General HospitalBayer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedMelanomaUnited States